{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:49:00Z","timestamp":1791384540084,"version":"4.3.3"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173767"],"award-info":[{"award-number":["82173767"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-09057-w","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T17:28:24Z","timestamp":1764005304000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["PfPI3K inhibition reversed artemisinin resistance by increasing ROS and ubiquitinated protein levels in Plasmodium falciparum"],"prefix":"10.1038","volume":"8","author":[{"given":"Nan","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanjiangyue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2359-2673","authenticated-orcid":false,"given":"Yujie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9741-7969","authenticated-orcid":false,"given":"Shuqiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"9057_CR1","doi-asserted-by":"crossref","unstructured":"Venkatesan P. WHO World Malaria Report 2024. Lancet Microbe 6, 101073 (2025).","DOI":"10.1016\/j.lanmic.2025.101073"},{"key":"9057_CR2","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S0140-6736(13)60024-0","volume":"383","author":"NJ White","year":"2014","unstructured":"White, N. J. et al. Malaria. Lancet 383, 723\u201335 (2014).","journal-title":"Lancet"},{"key":"9057_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature15535","volume":"526","author":"S Bhatt","year":"2015","unstructured":"Bhatt, S. et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature 526, 207\u2013211 (2015).","journal-title":"Nature"},{"key":"9057_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2022.102193","volume":"69","author":"KE Ward","year":"2022","unstructured":"Ward, K. E., Fidock, D. A. & Bridgford, J. L. Plasmodium falciparum resistance to artemisinin-based combination therapies. Curr. Opin. Microbiol. 69, 102193 (2022).","journal-title":"Curr. Opin. Microbiol."},{"key":"9057_CR5","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1056\/NEJMoa1606701","volume":"375","author":"PW Gething","year":"2016","unstructured":"Gething, P. W. et al. Mapping Plasmodium falciparum mortality in Africa between 1990 and 2015. N. Engl. J. Med. 375, 2435\u20132445 (2016).","journal-title":"N. Engl. J. Med."},{"key":"9057_CR6","doi-asserted-by":"publisher","first-page":"e540","DOI":"10.1016\/S1473-3099(24)00427-4","volume":"24","author":"A Bj\u00f6rkman","year":"2024","unstructured":"Bj\u00f6rkman, A., Gil, P. & Alifrangis, M. Alarming Plasmodium falciparum resistance to artemisinin-based combination therapy in Africa: the critical role of the partner drug. Lancet Infect. Dis. 24, e540\u2013e541 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"9057_CR7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ijpddr.2021.05.007","volume":"16","author":"FA Siddiqui","year":"2021","unstructured":"Siddiqui, F. A., Liang, X. & Cui, L. Plasmodium falciparum resistance to ACTs: emergence, mechanisms, and outlook. Int J. Parasitol. Drugs Drug Resist. 16, 102\u2013118 (2021).","journal-title":"Int J. Parasitol. Drugs Drug Resist."},{"key":"9057_CR8","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/S1473-3099(19)30391-3","volume":"19","author":"RW van der Pluijm","year":"2019","unstructured":"van der Pluijm, R. W. et al. Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study. Lancet Infect. Dis. 19, 952\u2013961 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"9057_CR9","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S1473-3099(15)70049-6","volume":"15","author":"MD Spring","year":"2015","unstructured":"Spring, M. D. et al. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study. Lancet Infect. Dis. 15, 683\u201391 (2015).","journal-title":"Lancet Infect. Dis."},{"key":"9057_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1473-3099(15)00487-9","volume":"16","author":"C Amaratunga","year":"2016","unstructured":"Amaratunga, C. et al. Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study. Lancet Infect. Dis. 16, 357\u201365 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"9057_CR11","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","volume":"385","author":"B Balikagala","year":"2021","unstructured":"Balikagala, B. et al. Evidence of artemisinin-resistant malaria in Africa. N. Engl. J. Med. 385, 1163\u20131171 (2021).","journal-title":"N. Engl. J. Med."},{"key":"9057_CR12","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nrmicro.2017.161","volume":"16","author":"K Haldar","year":"2018","unstructured":"Haldar, K., Bhattacharjee, S. & Safeukui, I. Drug resistance in Plasmodium. Nat. Rev. Microbiol. 16, 156\u2013170 (2018).","journal-title":"Nat. Rev. Microbiol."},{"key":"9057_CR13","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nature14412","volume":"520","author":"A Mbengue","year":"2015","unstructured":"Mbengue, A. et al. A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria. Nature 520, 683\u20137 (2015).","journal-title":"Nature"},{"key":"9057_CR14","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1182\/blood-2009-08-238972","volume":"115","author":"A Vaid","year":"2010","unstructured":"Vaid, A., Ranjan, R., Smythe, W. A., Hoppe, H. C. & Sharma, P. PfPI3K, a phosphatidylinositol-3 kinase from Plasmodium falciparum, is exported to the host erythrocyte and is involved in hemoglobin trafficking. Blood 115, 2500\u20137 (2010).","journal-title":"Blood"},{"key":"9057_CR15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley, E. A. et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 371, 411\u201323 (2014).","journal-title":"N. Engl. J. Med."},{"key":"9057_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/srep13891","volume":"5","author":"BT Mott","year":"2015","unstructured":"Mott, B. T. et al. High-throughput matrix screening identifies synergistic and antagonistic antimalarial drug combinations. Sci. Rep. 5, 13891 (2015).","journal-title":"Sci. Rep."},{"key":"9057_CR17","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nmeth.4223","volume":"14","author":"J Birnbaum","year":"2017","unstructured":"Birnbaum, J. et al. A genetic system to study Plasmodium falciparum protein function. Nat. Methods 14, 450\u2013456 (2017).","journal-title":"Nat. Methods"},{"key":"9057_CR18","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1158\/1078-0432.CCR-14-2034","volume":"21","author":"Q Yang","year":"2015","unstructured":"Yang, Q., Modi, P., Newcomb, T., Qu\u00e9va, C. & Gandhi, V. Idelalisib: first-in-class PI3K delta inhibitor for the treatment of chronic lymphocytic leukemia, small lymphocytic leukemia, and follicular lymphoma. Clin. Cancer Res. 21, 1537\u201342 (2015).","journal-title":"Clin. Cancer Res."},{"key":"9057_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111275","volume":"136","author":"K Yadav","year":"2021","unstructured":"Yadav, K. et al. Repurposing of existing therapeutics to combat drug-resistant malaria. Biomed. Pharmacother. 136, 111275 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"9057_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06221-1","volume":"9","author":"JL Bridgford","year":"2018","unstructured":"Bridgford, J. L. et al. Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome. Nat. Commun. 9, 3801 (2018).","journal-title":"Nat. Commun."},{"key":"9057_CR21","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1073\/pnas.1600459113","volume":"113","author":"HM Ismail","year":"2016","unstructured":"Ismail, H. M. et al. Artemisinin activity-based probes identify multiple molecular targets within the asexual stage of the malaria parasites Plasmodium falciparum 3D7. Proc. Natl. Acad. Sci. USA 113, 2080\u20135 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9057_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10111","volume":"6","author":"J Wang","year":"2015","unstructured":"Wang, J. et al. Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum. Nat. Commun. 6, 10111 (2015).","journal-title":"Nat. Commun."},{"key":"9057_CR23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1128\/AAC.03663-14","volume":"59","author":"AM Gopalakrishnan","year":"2015","unstructured":"Gopalakrishnan, A. M. & Kumar, N. Antimalarial action of artesunate involves DNA damage mediated by reactive oxygen species. Antimicrob. Agents Chemother. 59, 317\u201325 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9057_CR24","doi-asserted-by":"publisher","first-page":"4941","DOI":"10.1016\/j.bmc.2003.09.011","volume":"11","author":"L Soul\u00e8re","year":"2003","unstructured":"Soul\u00e8re, L. et al. Screening of Plasmodium falciparum iron superoxide dismutase inhibitors and accuracy of the SOD-assays. Bioorg. Med. Chem. 11, 4941\u20134 (2003).","journal-title":"Bioorg. Med. Chem."},{"key":"9057_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0166-6851(03)00161-0","volume":"130","author":"SE Akerman","year":"2003","unstructured":"Akerman, S. E. & M\u00fcller, S. 2-Cys peroxiredoxin PfTrx-Px1 is involved in the antioxidant defence of Plasmodium falciparum. Mol. Biochem. Parasitol. 130, 75\u201381 (2003).","journal-title":"Mol. Biochem. Parasitol."},{"key":"9057_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parint.2007.08.001","volume":"57","author":"S Kawazu","year":"2008","unstructured":"Kawazu, S., Komaki-Yasuda, K., Oku, H. & Kano, S. Peroxiredoxins in malaria parasites: parasitologic aspects. Parasitol. Int. 57, 1\u20137 (2008).","journal-title":"Parasitol. Int."},{"key":"9057_CR27","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1111\/j.1365-2958.2004.04257.x","volume":"53","author":"S M\u00fcller","year":"2004","unstructured":"M\u00fcller, S. Redox and antioxidant systems of the malaria parasite Plasmodium falciparum. Mol. Microbiol. 53, 1291\u2013305 (2004).","journal-title":"Mol. Microbiol."},{"key":"9057_CR28","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S1471-4922(02)02293-6","volume":"18","author":"RP Hirt","year":"2002","unstructured":"Hirt, R. P., M\u00fcller, S., Embley, T. M. & Coombs, G. H. The diversity and evolution of thioredoxin reductase: new perspectives. Trends Parasitol. 18, 302\u20138 (2002).","journal-title":"Trends Parasitol."},{"key":"9057_CR29","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1042\/bj3460545","volume":"346","author":"K L\u00fcersen","year":"2000","unstructured":"L\u00fcersen, K., Walter, R. D. & M\u00fcller, S. Plasmodium falciparum-infected red blood cells depend on a functional glutathione de novo synthesis attributable to an enhanced loss of glutathione. Biochem. J. 346, 545\u201352 (2000).","journal-title":"Biochem. J."},{"key":"9057_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00203-5","volume":"8","author":"MZ Chen","year":"2017","unstructured":"Chen, M. Z. et al. A thiol probe for measuring unfolded protein load and proteostasis in cells. Nat. Commun. 8, 474 (2017).","journal-title":"Nat. Commun."},{"key":"9057_CR31","doi-asserted-by":"publisher","first-page":"6511","DOI":"10.1002\/ange.201512062","volume":"128","author":"HM Ismail","year":"2016","unstructured":"Ismail, H. M. et al. A click chemistry-based proteomic approach reveals that 1,2,4-trioxolane and artemisinin antimalarials share a common protein alkylation profile. Angew. Chem. Int. Ed. Engl. 128, 6511\u20136515 (2016).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"9057_CR32","doi-asserted-by":"publisher","first-page":"e1000382","DOI":"10.1371\/journal.pgen.1000382","volume":"5","author":"EM Tank","year":"2009","unstructured":"Tank, E. M. & True, H. L. Disease-associated mutant ubiquitin causes proteasomal impairment and enhances the toxicity of protein aggregates. PLoS Genet. 5, e1000382 (2009).","journal-title":"PLoS Genet."},{"key":"9057_CR33","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.tcb.2014.05.003","volume":"24","author":"MS Hipp","year":"2014","unstructured":"Hipp, M. S., Park, S. H. & Hartl, F. U. Proteostasis impairment in protein-misfolding and -aggregation diseases. Trends Cell Biol. 24, 506\u201314 (2014).","journal-title":"Trends Cell Biol."},{"key":"9057_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrm1052","volume":"4","author":"L Ellgaard","year":"2003","unstructured":"Ellgaard, L. & Helenius, A. Quality control in the endoplasmic reticulum. Nat. Rev. Mol. Cell Biol. 4, 181\u201391 (2003).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"9057_CR35","doi-asserted-by":"publisher","first-page":"5602","DOI":"10.1074\/jbc.M806664200","volume":"284","author":"P Tongaonkar","year":"2009","unstructured":"Tongaonkar, P. & Selsted, M. E. SDF2L1, a component of the endoplasmic reticulum chaperone complex, differentially interacts with {alpha}-, {beta}-, and {theta}-defensin propeptides. J. Biol. Chem. 284, 5602\u20139 (2009).","journal-title":"J. Biol. Chem."},{"key":"9057_CR36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature04104","volume":"438","author":"DJ LaCount","year":"2005","unstructured":"LaCount, D. J. et al. A protein interaction network of the malaria parasite Plasmodium falciparum. Nature 438, 103\u20137 (2005).","journal-title":"Nature"},{"key":"9057_CR37","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1371\/journal.pcbi.0030168","volume":"3","author":"SR Pavithra","year":"2007","unstructured":"Pavithra, S. R., Kumar, R. & Tatu, U. Systems analysis of chaperone networks in the malarial parasite Plasmodium falciparum. PLoS Comput. Biol. 3, 1701\u201315 (2007).","journal-title":"PLoS Comput. Biol."},{"key":"9057_CR38","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.chom.2017.11.005","volume":"22","author":"M Zhang","year":"2017","unstructured":"Zhang, M. et al. Inhibiting the Plasmodium eIF2\u03b1 kinase PK4 prevents artemisinin-induced latency. Cell Host Microbe. 22, 766\u2013776.e4 (2017).","journal-title":"Cell Host Microbe."},{"key":"9057_CR39","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1038\/s42003-024-07178-2","volume":"7","author":"A Rahman","year":"2024","unstructured":"Rahman, A. et al. Artemisinin-resistant Plasmodium falciparum Kelch13 mutant proteins display reduced heme-binding affinity and decreased artemisinin activation. Commun. Biol. 7, 1499 (2024).","journal-title":"Commun. Biol."},{"key":"9057_CR40","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nature12361","volume":"499","author":"L Jiang","year":"2013","unstructured":"Jiang, L. et al. PfSETvs methylation of histone H3K36 represses virulence genes in Plasmodium falciparum. Nature 499, 223\u20137 (2013).","journal-title":"Nature"},{"key":"9057_CR41","doi-asserted-by":"publisher","first-page":"418","DOI":"10.2307\/3280287","volume":"65","author":"C Lambros","year":"1979","unstructured":"Lambros, C. & Vanderberg, J. P. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65, 418\u201320 (1979).","journal-title":"J. Parasitol."},{"key":"9057_CR42","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0091-679X(08)61853-1","volume":"45","author":"MJ Blackman","year":"1994","unstructured":"Blackman, M. J. Purification of Plasmodium falciparum merozoites for analysis of the processing of merozoite surface protein-1. Methods Cell Biol. 45, 213\u201320 (1994).","journal-title":"Methods Cell Biol."},{"key":"9057_CR43","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1550-7408.1983.tb02932.x","volume":"30","author":"EM Rivadeneira","year":"1983","unstructured":"Rivadeneira, E. M., Wasserman, M. & Espinal, C. T. Separation and concentration of schizonts of Plasmodium falciparum by Percoll gradients. J. Protozool. 30, 367\u201370 (1983).","journal-title":"J. Protozool."},{"key":"9057_CR44","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1073\/pnas.1813542116","volume":"116","author":"B Xiao","year":"2019","unstructured":"Xiao, B. et al. Epigenetic editing by CRISPR\/dCas9 in Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 116, 255\u2013260 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9057_CR45","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1093\/nar\/29.3.850","volume":"29","author":"K Deitsch","year":"2001","unstructured":"Deitsch, K., Driskill, C. & Wellems, T. Transformation of malaria parasites by the spontaneous uptake and expression of DNA from human erythrocytes. Nucleic Acids Res. 29, 850\u20133 (2001).","journal-title":"Nucleic Acids Res."},{"key":"9057_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-2-19","volume":"2","author":"TS Skinner-Adams","year":"2003","unstructured":"Skinner-Adams, T. S., Lawrie, P. M., Hawthorne, P. L., Gardiner, D. L. & Trenholme, K. R. Comparison of Plasmodium falciparum transfection methods. Malar. J. 2, 19 (2003).","journal-title":"Malar. J."},{"key":"9057_CR47","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.molbiopara.2013.01.001","volume":"187","author":"S Hasenkamp","year":"2013","unstructured":"Hasenkamp, S., Merrick, C. J. & Horrocks, P. A quantitative analysis of Plasmodium falciparum transfection using DNA-loaded erythrocytes. Mol. Biochem. Parasitol. 187, 117\u201320 (2013).","journal-title":"Mol. Biochem. Parasitol."},{"key":"9057_CR48","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.23239","volume":"6","author":"ES Sherling","year":"2017","unstructured":"Sherling, E. S. et al. The Plasmodium falciparum rhoptry protein RhopH3 plays essential roles in host cell invasion and nutrient uptake. Elife 6, e23239 (2017). pii.","journal-title":"Elife"},{"key":"9057_CR49","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01972-19","volume":"10","author":"ML Wilde","year":"2019","unstructured":"Wilde, M. L. et al. Protein kinase A is essential for invasion of Plasmodium falciparum into human erythrocytes. mBio. 10, e01972-19 (2019).","journal-title":"mBio."},{"key":"9057_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-017-1845-5","volume":"16","author":"A Mukherjee","year":"2017","unstructured":"Mukherjee, A. et al. Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia. Malar. J. 16, 195 (2017).","journal-title":"Malar. J."},{"key":"9057_CR51","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/S1473-3099(13)70252-4","volume":"13","author":"B Witkowski","year":"2013","unstructured":"Witkowski, B. et al. Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in vitro and ex vivo drug-response studies. Lancet Infect. Dis. 13, 1043\u20139 (2013).","journal-title":"Lancet Infect. Dis."},{"key":"9057_CR52","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02309-17","volume":"62","author":"A Mukherjee","year":"2018","unstructured":"Mukherjee, A., Gagnon, D., Wirth, D. F. & Richard, D. Inactivation of Plasmepsins 2 and 3 sensitizes Plasmodium falciparum to the antimalarial drug piperaquine. Antimicrob. Agents Chemother. 62, e02309-17 (2018).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9057_CR53","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","volume":"48","author":"M Smilkstein","year":"2004","unstructured":"Smilkstein, M., Sriwilaijaroen, N., Kelly, J. X., Wilairat, P. & Riscoe, M. Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob. Agents Chemother. 48, 1803\u20136 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9057_CR54","first-page":"452","volume":"10","author":"WA Smythe","year":"2008","unstructured":"Smythe, W. A., Joiner, K. A. & Hoppe, H. C. Actin is required for endocytic trafficking in the malaria parasite Plasmodium falciparum. Cell Microbiol. 10, 452\u201364 (2008).","journal-title":"Cell Microbiol."},{"key":"9057_CR55","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1128\/AAC.48.7.2370-2378.2004","volume":"48","author":"HC Hoppe","year":"2004","unstructured":"Hoppe, H. C. et al. Antimalarial quinolines and artemisinin inhibit endocytosis in Plasmodium falciparum. Antimicrob. Agents Chemother. 48, 2370\u20138 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9057_CR56","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1074\/mcp.RA119.001797","volume":"19","author":"GW Birrell","year":"2020","unstructured":"Birrell, G. W. et al. Multi-omic characterization of the mode of action of a potent new antimalarial compound, JPC-3210, against Plasmodium falciparum. Mol. Cell Proteom. 19, 308\u2013325 (2020).","journal-title":"Mol. Cell Proteom."},{"key":"9057_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-015-0729-9","volume":"14","author":"JM Combrinck","year":"2015","unstructured":"Combrinck, J. M. et al. Optimization of a multi-well colorimetric assay to determine haem species in Plasmodium falciparum in the presence of anti-malarials. Malar. J. 14, 253 (2015).","journal-title":"Malar. J."},{"key":"9057_CR58","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1021\/cb300454t","volume":"8","author":"JM Combrinck","year":"2013","unstructured":"Combrinck, J. M. et al. Insights into the role of heme in the mechanism of action of antimalarials. ACS Chem. Biol. 8, 133\u20137 (2013).","journal-title":"ACS Chem. Biol."},{"key":"9057_CR59","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03239-21","volume":"13","author":"A Mukherjee","year":"2022","unstructured":"Mukherjee, A. et al. A phosphoinositide-binding protein acts in the trafficking pathway of hemoglobin in the malaria parasite Plasmodium falciparum. mBio. 13, e0323921 (2022).","journal-title":"mBio"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09057-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09057-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09057-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T18:13:16Z","timestamp":1764180796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09057-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9057"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-09057-w","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"27 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1661"}}